Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001251065 | SCV000697139 | uncertain significance | not specified | 2020-07-16 | criteria provided, single submitter | clinical testing | Variant summary: HBB c.56T>G (p.Val19Gly) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251262 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.56T>G has been reported in the literature but the carriers were found to have a mild or no phenotype (Pobedimskaya_1993, Smith_2016). Spuriously low values of HbA1c was also noted in an individual carrying this variant (Smith_2013). These reports however, do not provide unequivocal conclusions about association of the variant with Hemoglobinopathy. The variant was found to be unstable in functional studies (Pobedimskaya_1993, Scheps_2019). One other ClinVar submitter (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000589269 | SCV001134234 | uncertain significance | not provided | 2020-02-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834854 | SCV002091599 | uncertain significance | beta Thalassemia | 2020-12-27 | no assertion criteria provided | clinical testing |